Vitamin DResistant Rickets

There are a number of rachitic syndromes that do not respond to normal amounts of vitamin D:

1. X-linked hypophosphatemic rickets is caused by abnormal reabsorption of phosphate in the proximal renal tubule, resulting in excessive excretion of phosphate and hence hypophosphatemia. There may also be blunting of the normal increase in calcidiol 1-hydroxylase activity in response to hypophosphatemia. The gene responsible for the condition has been identified (the PHEX gene); its product is a membrane-bound endopeptidase that normally acts to clear the hormone phosphatonin from the circulation. Phosphatonin acts to decrease the activity of the sodium/phosphate cotransporter in the kidney (Drezner, 2000).

2. Tumor-induced osteomalacia (oncogenic hypophosphatemic osteomalacia) is also characterized by excessive urinary excretion of phosphate, and hence hypophosphatemia and low circulating calcitriol. Removal of the tumor results in normalization of phosphate excretion and recovery from osteomalacia. The tumors that cause osteomalacia secrete abnormally large amounts of phosphatonin (Kumar, 2000).

3. Type I vitamin D-resistant rickets is due to a genetic defect in calcidiol 1-hydroxylase, so that little or no calcitriol is formed. Patients respond well to the administration of 1a-hydroxycholecalciferol, which is a substrate for 25-hydroxylation in the liver, leading to normal circulating concentrations of calcitriol.

4. Type II vitamin D-resistant rickets is characterized by a lack of responsiveness of target tissues to calcitriol and is caused by a genetic defect in the calcitriol receptor. Affected children develop more or less normally until about 9 months of age, then develop severe rickets with alopecia and a wide variety of disorders, including immune system dysfunction. Three variants are known:

(a) Complete absence of calcitriol receptor, presumably the result of a deletion or early nonsense mutation in the receptor gene.

(b) Poor affinity of the receptor for calcitriol, presumably the result of a mutation affecting the calcitriol binding site.

(c) Normal receptor binding of calcitriol with impaired responsiveness of target tissues, presumably the result of a mutation affecting the DNA binding domain of the receptor.

Hair Loss Prevention

Hair Loss Prevention

The best start to preventing hair loss is understanding the basics of hair what it is, how it grows, what system malfunctions can cause it to stop growing. And this ebook will cover the bases for you. Note that the contents here are not presented from a medical practitioner, and that any and all dietary and medical planning should be made under the guidance of your own medical and health practitioners. This content only presents overviews of hair loss prevention research for educational purposes and does not replace medical advice from a professional physician.

Get My Free Ebook

Post a comment